...
首页> 外文期刊>Annals of medicine >Thoracic endovascular aortic repair versus open chest surgical repair for patients with type B aortic dissection: a systematic review and meta-analysis
【24h】

Thoracic endovascular aortic repair versus open chest surgical repair for patients with type B aortic dissection: a systematic review and meta-analysis

机译:B型主动脉扫描患者的胸腔血管内主动脉修复与开放式胸外科修复:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aim: This meta-analysis study aimed to compare the efficacy and safety of TEVAR versus OCSR for TBAD patients. Methods: We systematically searched PubMed, EmBase, and the Cochrane library to identify studies compared the effectiveness of TEVAR and OCSR in TBAD patients from the inception up to July 2019. The summary results were calculated using a random-effects model. Results: The electronic search identified 1,894 studies, and 18 studies with 9,664 TBAD patients were included. We noted patients received TEVAR were associated with a reduced risk of in-hospital mortality, acute renal failure, respiratory failure, and bleeding as compared with OCSR, whereas no significant differences between groups for the risk of stroke, myocardial infarction, paraplegia, mesenteric ischaemia/infarction, reinterventions, sepsis, and spinal cord ischaemia. Conclusions: The findings of this meta-analysis study suggested that TEVAR resulted in more short-term survival benefits. Moreover, the reduced risk of acute renal failure, respiratory failure and bleeding was detected in TEVAR group. The treatment effects of TEVAR versus OCSR on specific complications should be further verified by a study with high-level of evidence.Key message Comprehensive collected studies investigated the treatment effectiveness between TEVAR and OCSR for TBAD patients TEVAR resulted in more survival benefits, in addition to lower risk of acute renal failure, respiratory failure and bleeding The results of stratified analyses according to patients' characteristics were conducted
机译:目的:这种荟萃分析研究旨在比较TBAD患者TEVAR对OCSR的疗效和安全性。方法:我们系统地搜索了PubMed,Embase和Cochrane库以识别研究比较TBAD患者TBAD患者的TPAD和OCSR的有效性从2009年7月开始。摘要结果是使用随机效应模型计算的。结果:电子搜索确定了1,894项研究,其中包括9,664名TBAD患者的18项研究。与OCSR相比,我们注意到患者接受TEVAR的患者与医院内死亡率降低,急性肾功能衰竭,呼吸衰竭,呼吸衰竭和出血。患有中风,心肌梗死,截瘫患者,肠系膜血症的风险没有显着差异/梗死,重新融合,败血症和脊髓缺血性。结论:这种荟萃分析研究的结果表明,Tevar导致了更短期的生存效益。此外,在TEVAR组中检测到急性肾衰竭,呼吸衰竭和出血的风险降低。 Tevar对OCSR对特异性并发症的治疗效果应进一步通过高水平的证据进一步验证.Key留言全面收集的研究调查了TBAD患者TPAD和OCSR之间的治疗效果,除了急性肾功能衰竭,呼吸衰竭和出血的风险降低,根据患者特征进行分层分析结果

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号